Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2025-04-11 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
关于控股股东上层股权结构拟发生变动的提示性公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (915 characters) regarding a proposed change in the equity structure of the company's controlling shareholder. It explicitly states that the controlling shareholder and actual controller remain unchanged and that the change will not materially affect the company's operations. There are no financial statements, detailed financial data, or comprehensive reports included. The document serves as a notification of a corporate governance-related event rather than a full report or detailed filing. It fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about shareholding structure changes that do not meet the threshold for Major Shareholding Notification (MRQ) since it does not indicate crossing ownership thresholds or new significant share ownership. It is not a full report, audit, or management information, nor is it a voting or dividend announcement. Therefore, the best classification is Regulatory Filings (RNS).
2025-04-11 Chinese
关于全资子公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (889 characters) from a company about its wholly owned subsidiary receiving medical device registration change documents issued by a regulatory authority (Guangdong Provincial Drug Administration). It describes the registration certificate changes for certain medical products and their impact on the company. There are no financial statements, no detailed financial data, no earnings or management discussion, and no mention of an annual or interim report. The document is an official announcement of a regulatory approval/change related to product registration, not a financial report or management report. It fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement that does not fit into other specific categories like capital update, earnings release, or management information. The document is not a report publication announcement since it does not mention any report being published or attached, but rather a regulatory approval notice. Confidence is high due to clear regulatory content and short length.
2025-04-08 Chinese
关于珠海格金阳普大健康产业基金合伙企业（有限合伙）完成工商注销登记的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from 阳普医疗科技股份有限公司 regarding the completion of the deregistration (工商注销登记) of a partnership fund (珠海格金阳普大健康产业基金合伙企业). It references previous announcements about withdrawing from the fund and states that the fund will no longer be included in the company's consolidated financial statements. The document is short (659 characters) and serves as a formal notice of a corporate event related to the company's capital or investment structure. It does not contain financial statements or detailed financial data, nor is it a report or presentation. This fits best under Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes.
2025-04-03 Chinese
关于高级管理人员辞职的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the resignation of a senior management member, specifically the vice general manager of the company. It details the resignation date, the individual's remaining roles, and compliance with relevant regulations. There is no financial data, no mention of a report or meeting, and it focuses solely on management changes. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing. Hence, the classification is MANG with high confidence.
2025-02-28 Chinese
关于全资子公司取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (690 characters) about the company's wholly owned subsidiary obtaining a medical device registration certificate issued by a regulatory authority. It describes the certificate details and the potential impact on the company but does not contain any financial data, detailed financial statements, or comprehensive report content. It is an official announcement regarding a regulatory approval rather than a financial report or management discussion. The document length and content indicate it is not a full report but a regulatory announcement. Therefore, it fits best under Regulatory Filings (RNS).
2025-02-11 Chinese
关于公司收到医疗器械变更注册（备案）文件的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (620 characters) regarding the receipt of a medical device registration change document issued by a regulatory authority (Guangdong Provincial Drug Administration). It details a change in the company's registered address for a medical device product. The document explicitly states it is an announcement about receiving a regulatory filing and does not contain financial data, management discussion, or detailed report content. It is not a full report but a regulatory announcement about a compliance matter. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-01-20 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.